Detalhe da pesquisa
1.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Ann Oncol
; 33(12): 1250-1268, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228963
2.
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.
Clin Transl Oncol
; 22(8): 1364-1377, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052382
3.
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain.
Clin Transl Oncol
; 20(6): 753-760, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116433